Cabazitaxel for the Treatment of mCRPC: Data From the CARD Trial


Dr Shore continues his review of data on cabazitaxel for the treatment of mCRPC by highlighting efficacy data from the CARD trial and real-world data that could impact practice.

Related Videos
Blur image of hospital corridor | Image Credit: © zephyr_p -
blur image background of corridor in hospital or clinic image | Image Credit @ whyframeshot -
Dr. Mehmet Asim Bilen in an interview with Urology Times
Related Content
© 2024 MJH Life Sciences

All rights reserved.